home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Optimizing Drug Loading in Amorphous Solid Dispersions: Maximizing Bioavailability While Minimizing Pill Burden

 
  April 01, 2025  
     
 
Xtalks, Online
2025-04-30


Amorphous solid dispersions (ASDs) have revolutionized drug delivery by enhancing the bioavailability of poorly soluble drugs.

However, formulators often assume that higher drug loading in ASDs will automatically reduce pill burden by minimizing excipient content. This approach overlooks a critical factor: increasing the drug-to-polymer ratio can significantly reduce the fraction of drug absorbed, ultimately leading to higher doses and offsetting any initial benefits of reduced formulation mass.

In this webinar, the expert speaker will challenge this common misconception and provide a framework for optimizing ASD formulations to achieve both maximum bioavailability and minimal pill burden. Through scientific insights and real-world examples, the speaker will provide formulation scientists and drug developers with the knowledge needed to make data-driven decisions when designing ASDs.

The following topics will be discussed:

Explore the critical role of drug-polymer interactions in maintaining supersaturation within the gastrointestinal tract
How the drug-to-polymer ratio affects both the fraction of drug absorbed and the overall pill burden
Why higher drug loading may not always result in more efficient formulations and could lead to increased dosage requirements
The impact of ASD particle morphology on dissolution performance
Insights from case studies that demonstrate effective strategies for ASD optimization to reduce overall dosage and tablet count

Register for this webinar to learn how to balance polymer selection, drug loading and particle morphology to create the most effective and patient-friendly drug products.

Keywords: Drug Development, Drug Delivery, CRO, Drug Manufacturing, Bioavailability, Amorphous Solid Dispersions, API/Formulation Development, CDMO/CMO, ASD
 
 
Organized by: Xtalks
Invited Speakers: Dave Miller, PhD, Chief Scientific Officer, AustinPx
 
Deadline for Abstracts: 2025-04-30
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2025 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.